Page last updated: 2024-09-05

sorafenib and dapagliflozin

sorafenib has been researched along with dapagliflozin in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(dapagliflozin)
Trials
(dapagliflozin)
Recent Studies (post-2010) (dapagliflozin)
6,5207305,2511,4783681,407

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)dapagliflozin (IC50)
Sodium/glucose cotransporter 1Homo sapiens (human)1.1661
Sodium/glucose cotransporter 2Homo sapiens (human)0.0022
Sodium/myo-inositol cotransporter 2Homo sapiens (human)0.38
Solute carrier family 5 member 4Homo sapiens (human)0.0014

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cui, Y; Dong, Z; Fu, Y; He, X; Li, Y; Ma, Y; Xun, X1

Other Studies

1 other study(ies) available for sorafenib and dapagliflozin

ArticleYear
Development of UPLC-MS/MS Method to Study the Pharmacokinetic Interaction between Sorafenib and Dapagliflozin in Rats.
    Molecules (Basel, Switzerland), 2022, Sep-21, Volume: 27, Issue:19

    Topics: Acetonitriles; Animals; Benzhydryl Compounds; Carcinoma, Hepatocellular; Chromatography, High Pressure Liquid; Chromatography, Liquid; Diabetes Mellitus, Type 2; Glucose; Glucosides; Glucuronosyltransferase; Liver Neoplasms; Rats; Reproducibility of Results; RNA, Messenger; Sodium; Sodium-Glucose Transporter 2 Inhibitors; Sorafenib; Tandem Mass Spectrometry; Uridine Diphosphate

2022